Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

86.17
-1.0000-1.15%
Post-market: 86.340.1700+0.20%18:27 EDT
Volume:1.74M
Turnover:150.17M
Market Cap:3.00B
PE:-19.01
High:88.10
Open:85.64
Low:85.02
Close:87.17
52wk High:95.95
52wk Low:30.82
Shares:34.77M
Float Shares:28.68M
Volume Ratio:1.88
T/O Rate:6.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5319
EPS(LYR):-3.9613
ROE:-26.36%
ROA:-17.95%
PB:4.88
PE(LYR):-21.75

Loading ...

Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Aug 07

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025

Dow Jones
·
Aug 07

Director Kevin Bitterman Reports Disposal of Common Shares of Disc Medicine Inc. i

Reuters
·
Aug 02

Press Release: CHAMPION IRON REPORTS ITS FY2026 FIRST QUARTER RESULTS, AND ADVANCES THE DRPF PROJECT AS SCHEDULED

Dow Jones
·
Jul 30

Director Kevin Bitterman Reports Disposal of Common Shares of Disc Medicine Inc

Reuters
·
Jul 26

Director Kevin Bitterman Reports Disposal of Common Shares in Disc Medicine Inc

Reuters
·
Jul 23

Truist Securities Initiates Coverage on Disc Medicine With Buy Rating, $86 Price Target

MT Newswires Live
·
Jul 21

Disc Medicine Inc. Announces Positive Pre-NDA Meeting with FDA and Plans to Submit NDA for Bitopertin in October 2025

Reuters
·
Jul 21

CFO Jean M. Franchi Reports Disposal of Common Shares in Disc Medicine Inc

Reuters
·
Jul 19

Disc Medicine Inc. Files Initial Beneficial Ownership Statement for Director Nadim Ahmed

Reuters
·
Jul 17

Jean M. Franchi, CFO, Reports Disposal of Common Shares of Disc Medicine Inc

Reuters
·
Jul 15

Disc Medicine Inc. Appoints Nadim Ahmed to Board of Directors Amid Strategic Growth Initiatives

Reuters
·
Jul 14

CEO John D. Quisel Reports Disposal of Common Shares of Disc Medicine Inc

Reuters
·
Jul 09

Disc Medicine Coverage Assumed by Morgan Stanley at Overweight

Dow Jones
·
Jul 04

Disc Medicine Price Target Maintained With a $118.00/Share by HC Wainwright & Co.

Dow Jones
·
Jul 03

CFO Jean M. Franchi Reports Disposal of Common Shares of Disc Medicine Inc

Reuters
·
Jun 19

Disc Medicine Price Target Maintained With a $118.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 17

Disc Medicine Inc. Unveils Presentation on Innovative Approaches to Hematologic Disorders Targeting Iron and Heme Metabolism

Reuters
·
Jun 16

Disc Medicine Inc. Unveils EHA 2025 Corporate Presentation Highlighting Investigational Agents and Clinical Program Updates

Reuters
·
Jun 16

Disc Medicine Inc. i Conducted Annual Stockholders Meeting

Reuters
·
Jun 14